In a filing, Phio Pharmaceuticals Corp revealed its Chairman, Pres. & CEO Bitterman Robert J acquired Company’s shares for reported $5700.0 on Nov 21 ’25. In the deal valued at $1.14 per share,5,000 shares were bought. As a result of this transaction, Bitterman Robert J now holds 281,421 shares worth roughly $0.33 million.
Then, Bitterman Robert J bought 5,000 shares, generating $6,350 in total proceeds. Upon buying the shares at $1.27, the Chairman, Pres. & CEO now owns 276,421 shares.
Before that, Bitterman Robert J bought 2,000 shares. Phio Pharmaceuticals Corp shares valued at $4,840 were divested by the Chairman, Pres & CEO at a price of $2.42 per share. As a result of the transaction, Bitterman Robert J now holds 27,149 shares, worth roughly $31492.839999999997.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early August with a ‘”a Buy”‘ rating.
Price Performance Review of PHIO
On Monday, Phio Pharmaceuticals Corp [NASDAQ:PHIO] saw its stock jump 3.57% to $1.16. Over the last five days, the stock has lost -12.12%. Phio Pharmaceuticals Corp shares have fallen nearly -51.26% since the year began. Nevertheless, the stocks have fallen -35.56% over the past one year. While a 52-week high of $9.79 was reached on 01/13/25, a 52-week low of $0.97 was recorded on 04/08/25.
Levels Of Support And Resistance For PHIO Stock
The 24-hour chart illustrates a support level at 1.1083, which if violated will result in even more drops to 1.0567. On the upside, there is a resistance level at 1.2283. A further resistance level may holdings at 1.2967.
How much short interest is there in Phio Pharmaceuticals Corp?
A steep rise in short interest was recorded in Phio Pharmaceuticals Corp stocks on 2025-10-31, dropping by 42851.0 shares to a total of 0.23 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 0.28 million shares. There was a decline of -18.45%, which implies that there is a negative sentiment for the stock.
